Search by Drug Name or NDC

    NDC 63323-0714-24 Perikabiven 333; 235; 71; 20; 7.5; 116; 164; 141; 116; 164; 187; 68; 116; 164; 124; 141; 94; 170; 105; 3.5; 116; 40; 4.8; 152 mg/100mL; mg/100mL; mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL Details

    Perikabiven 333; 235; 71; 20; 7.5; 116; 164; 141; 116; 164; 187; 68; 116; 164; 124; 141; 94; 170; 105; 3.5; 116; 40; 4.8; 152 mg/100mL; mg/100mL; mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL

    Perikabiven is a INTRAVENOUS INJECTION, EMULSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Kabi USA, LLC. The primary component is ALANINE; ARGININE; ASPARTIC ACID; CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; GLUTAMIC ACID; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE HYDROCHLORIDE; MAGNESIUM SULFATE HEPTAHYDRATE; METHIONINE; PHENYLALANINE; POTASSIUM CHLORIDE; PROLINE; SERINE; SODIUM .

    Product Information

    NDC 63323-0714
    Product ID 63323-714_19ddcce5-fefc-428d-a57a-7df023363e25
    Associated GPIs 80451010001626
    GCN Sequence Number 085282
    GCN Sequence Number Description AA 2.36%/D7.5W/fat/e-lytes no9 EMULSION 2.36%-7.5% INTRAVEN
    HIC3 C9C
    HIC3 Description PARENTERAL AMINO ACID SOLUTIONS AND COMBINATIONS
    GCN 54726
    HICL Sequence Number 049206
    HICL Sequence Number Description AMINO ACID 2.36 % NO.1/D7.5W/FAT EMULSIONS/ELECTROLYTES NO.9
    Brand/Generic Brand
    Proprietary Name Perikabiven
    Proprietary Name Suffix n/a
    Non-Proprietary Name Dextrose, Soybean oil, Electrolytes, Lysine, Phenylalanine, Leucine, Valine, Threonine, Methionine, Isoleucine, Tryptophan, Alanine, Arginine, Glycine, Proline, Histidine, Glutamic Acid, Serine, Aspartic Acid and Tyrosine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, EMULSION
    Route INTRAVENOUS
    Active Ingredient Strength 333; 235; 71; 20; 7.5; 116; 164; 141; 116; 164; 187; 68; 116; 164; 124; 141; 94; 170; 105; 3.5; 116; 40; 4.8; 152
    Active Ingredient Units mg/100mL; mg/100mL; mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL
    Substance Name ALANINE; ARGININE; ASPARTIC ACID; CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; GLUTAMIC ACID; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE HYDROCHLORIDE; MAGNESIUM SULFATE HEPTAHYDRATE; METHIONINE; PHENYLALANINE; POTASSIUM CHLORIDE; PROLINE; SERINE; SODIUM
    Labeler Name Fresenius Kabi USA, LLC
    Pharmaceutical Class Amino Acid [EPC], Amino Acids [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Mot
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA200656
    Listing Certified Through 2024-12-31

    Package

    NDC 63323-0714-24 (63323071424)

    NDC Package Code 63323-714-24
    Billing NDC 63323071424
    Package 2400 mL in 1 BAG (63323-714-24)
    Marketing Start Date 2014-08-25
    NDC Exclude Flag N
    Pricing Information N/A